Stock NKTR NEKTAR THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Nektar Therapeutics

Equities

NKTR

US6402681083

Real-time Estimate Cboe BZX
Other stock markets
 10:01:16 2024-04-30 am EDT 		5-day change 1st Jan Change
1.48 USD +1.37% Intraday chart for Nektar Therapeutics +0.35% +152.21%
Apr. 24 Biolojic Design Announces Nektar Therapeutics Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases CI
Mar. 19 Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NKTR Stock
  4. News Nektar Therapeutics
  5. MarketScreener Editorial Features